Modern concepts of erythematotelangiectatic rosacea pathogenesis and treatment

Abstract

Rosacea is a multifactorial chronic pathology characterized by a complex etiopathogenesis. Rosacea is represented by 4 subtypes: erythematotelangiectatic, papulopustular, rhinophyma and ophthalmic rosacea. Clinical manifestations of erythematotelangiectatic rosacea reduce the quality of human life, which is manifested by disorders of the psychoemotional sphere of varying severity. The erythematotelangiectatic subtype is influenced by two groups of trigger factors ― internal and external. Mandatory areas of patients management with rosacea in general include the triad of treatment: providing proper skin care, health education, a set of therapeutic measures. Rosacea drug therapy is divided into local and systemic. The main treatment for erythematotelangiectatic rosacea is to eliminate the vascular component and reduce the severity of transient and persistent erythema. Among the physiotherapeutic methods, the most promising today are considered to be laser therapy and an intense pulsed light system (IPL). The effectiveness of laser medicine in dermatology is due to the ability to selectively build up the laser of the chromophochic layer of the dermis. The mechanism of action of IPL-therapy is associated with the absorption of photons by internal or external chromophores, which are located in different layers of the skin, which can locally increase the temperature and cause destructed target formations. A review of the literature on pathogenesis, trigger factors, classification and modern treatment of eerythematotelangiectatic rosacea is based on an analysis of articles on the relevant topic 44 presented in information systems electronic library, PubMed, NCBI, Embase. Studies are described demonstrating the convincing effectiveness of the treatment of patients with lasers and the IPL system.